Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
EV/Core EBITDA

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 25.2531.8134.08--0.06

What is the latest EV/Core EBITDA ratio of CONCORD BIOTECH ?

The latest EV/Core EBITDA ratio of CONCORD BIOTECH is 25.25 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202625.25
Mar202531.81
Mar202434.08
Mar2023-
Mar2022-0.06

How is EV/Core EBITDA of CONCORD BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2026 25.25
-20.62
Mar2025 31.81
-6.66
Mar2024 34.08
0
Mar2023 0
100.00
Mar2022 -0.06 -

Other Financial Ratios of CONCORD BIOTECH


Compare EV/Core EBITDA ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹13,706.8 Cr 6.6% -3.3% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,122.0 Cr 0.7% -0.3% 3.2% Stock Analytics
DIVIS LABORATORIES ₹266,424.0 Cr 4% 8.9% 54.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,914.0 Cr 3.6% -0.5% 28.8% Stock Analytics
DR REDDYS LABORATORIES ₹114,599.0 Cr 2.5% 13.6% 9.4% Stock Analytics
CIPLA ₹113,112.0 Cr 3.2% 5% -11.9% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

6.6%

-3.3%

-15.5%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses